47.73.Z - Retail sale of pharmaceutical products
01.28.Z - Cultivation of spice, aromatic plants and plants used for pharmaceuticals
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.99.Z - Production of other products not classified elsewhere
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.91.Z - Intermediary retail sale, non-specialized
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0 | 0 | 0 | 0 |
Gross profit (loss) | 0 | 0 | 0 | 0 |
EBITDA | -0 | 0 | 0 | 0 |
Short time liabilities | 0,7 | 0 | 0 | 0 |
Other operating costs | 0 | 0 | 0 | 0 |
Equity capital | -1,7 | 0 | 0 | 0 |
Operating profit (EBIT) | -0 | 0 | 0 | 0 |
Assets | 0,1 | 0 | 0 | 0 |
Net profit (loss) | -0 | 0 | 0 | 0 |
Cash | 0 | 0 | 0 | 0 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 1,8 | 0 | 0 | 0 |
Working assets | 0,1 | 0 | 0 | 0 |
Other income costs | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 0,1 | -3,4 | ||
Equity capital to total assets | -2199,5 | 6,4 | ||
Gross profit margin | -111,2 | |||
EBITDA Margin | -108,7 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 0 | 0 | 0 |
Current financial liquidity indicator | 0.11689433455467224 | 0 | ||
Net dept to EBITDA | -440.03375244140625 | -431,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane